Butanoic acid impacts the i) increase of leptin release and insulin sensitivity, ii) decrease of hypercholesterolemia and hepatic steatosis, iii) decrease of HOMA-IR index and iv) modulation of cellular events that regulate the assembly and delivery of lipoproteins. The gene discussed is INS; the disease is fatty liver disease.